Federal Trade Commission accuses three drug middlemen of inflating insulin prices
In a lawsuit, the FTC accused Optum Rx, Caremark and Express Scripts of creating "a broken rebate system that inflated insulin drug prices, boosting PBM (prescription drug benefit managers) profits at the expense of vulnerable patients.
UnitedHealth Group Inc. closed $30.87 below its 52-week high ($607.94), which the company achieved on September 4th.
The majority of cuts will take place in December, according to a notice filed with the state of New Jersey this month.
UnitedHealth Group Inc. struck a tentative deal to settle a class action challenging the Wells Fargo & Co. target date funds ...
This was the stock's second consecutive day of losses.
UnitedHealth Group Inc (UNH) stock saw a decline, ending the day at $577.96 which represents a decrease of $-11.18 or -1.90% from the prior close of $589.14. The stock opened at $586.01 and touched a ...
Zacks.com on MSN2d
UnitedHealth at 19.09X P/E: Worth the Price or Time to Take Profits?UnitedHealth Group Incorporated UNH is currently viewed as expensive, with the stock trading at a 19.09X forward 12-month ...
UnitedHealth Group(NYSE:UNH) is currently experiencing significant developments that are shaping its business trajectory.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback